Dendreon News
Most Popular Dendreon Story
Gold out, Johnson in as troubled Dendreon aims for a turnaround
In the course of one short year, Dendreon CEO Mitch Gold went from biotech hero to zero as the long-anticipated rollout of the groundbreaking cancer vaccine Provenge stumbled badly out of the gate. Read more...
Latest Headlines
- February 1, 2012
- December 9, 2011
- November 21, 2011
- September 9, 2011
- September 8, 2011
- August 19, 2011
- August 15, 2011
- February 18, 2011
- February 17, 2011
- July 29, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
